Protection of oligodeoxynucleotides against nuclease degradation through association with self-assembling peptides
Source abstract
Abstract
Aggregates of the self-assembling peptide EAK16II or EAK16IV and oligodeoxynucleotides (ODNs) were prepared, and their stability upon diluting the solution was investigated by UV-vis spectroscopy. The aggregates prepared at pH 4 and pH 7 did not dissociate after the solution was diluted 5- and 10-fold. The resistance against Escherichia coli exonuclease I of the ODN located in the EAK-ODN aggregates was studied by fluorescence resonance energy transfer (FRET) after the ODN had aggregated with EAK16II or EAK16IV at pH 4 or pH 7. The effect that the peptide sequence, peptide concentration, pH, and centrifugation had on protecting the aggregated ODN against nuclease degradation was investigated. Significant nuclease resistance was obtained after the EAK-ODN aggregates had been prepared at pH 4, with an EAK16IV concentration greater than a threshold value, and ensuring that the solution was not centrifuged immediately after sample preparation. Centrifuging the EAK16IV-ODN solution immediately after sample preparation resulted in the loss of this nuclease protection. However, if the solution of EAK-ODN aggregates was centrifuged 24 h after sample preparation, the nuclease protection afforded by the EAK16IV-ODN aggregates to the ODN was maintained even after being subject to a 10-fold dilution and up to 4 rounds of centrifugation over 4 days.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (22)
Show source-provided references
1. Antisense strategies for oncogene inactivation10.1053/j.seminoncol.2005.09.003 ↗
2. Therapeutic applications of oligonucleotides
3. Antisense anticancer oligonucleotide therapeutics10.2174/1568009013334133 ↗
4. Delivery of G3139 using releasable PEG-linkers: impact on pharmacokinetic profile and anti-tumor efficacy10.1016/j.jconrel.2006.12.021 ↗
5. Delivery systems for antisense oligonucleotides10.1016/S0163-7258(00)00062-0 ↗
6. Progress in antisense technology: the end of the beginning10.1016/S0076-6879(00)13003-4 ↗
7. Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application10.1093/nar/21.24.5761 ↗
8. Peptide nucleic acids: versatile tools for gene therapy strategies10.1016/S0169-409X(00)00087-9 ↗
9. An antisense oligonucleotide primer10.1089/oli.1.1999.9.351 ↗
10. FRET-FCS as a tool to evaluate the stability of oligonucleotide drugs after intracellular delivery10.1016/j.jconrel.2004.11.019 ↗
11. Synthesis of a library of polycationic lipid core dendrimers and their evaluation in the delivery of an oligonucleotide with hVEGF inhibition10.1016/j.bmc.2006.03.029 ↗
12. Current status of polymeric gene delivery systems10.1016/j.addr.2006.03.007 ↗
13. Comparison of basic peptides- and lipid-based strategies for the delivery of splice correcting oligonucleotides10.1016/j.bbamem.2005.10.010 ↗
14. Interaction of a self-assembling peptide with oligonucleotides: complexation and aggregation10.1529/biophysj.106.102624 ↗
15. Unusually stable β-sheet formation of an ionic self-complementary oligopeptide10.1002/bip.360340508 ↗
16. Detection of undegraded oligonucleotides in vivo by fluorescence resonance energy transfer10.1074/jbc.271.1.380 ↗
17. Properties of helical polycytidylic acid10.1021/bi00902a028 ↗
18. Purification and characterization of a prolyl aminopeptidase from debaryomyces hansenii10.1128/AEM.69.1.227-232.2003 ↗
19. Role of the T5 gene D15 nuclease in the generation of nicked bacteriophage T5 DNA10.1128/jvi.24.1.177-193.1977 ↗
20. Lehninger · 1993
21. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides10.1016/S0167-4781(99)00141-4 ↗
22. Aging characteristics of protein precipitates produced by polyelectrolyte precipitation in turbulently agitated reactor10.1016/S0009-2509(02)00319-6 ↗